Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

UNCOVERED: Biogen earnings preview what to expect - Caught on Camera

Based in Cambridge, Massachusetts, Biogen Inc. (BIIB) is a prominent global biotechnology company dedicated to pioneering advancements in neuroscience. With a market cap of $32.76 billion, Biogen is renowned for its innovative portfolio that enhances patient care through cutting-edge therapies for neurological and neurodegenerative diseases. The company is set to announce its fiscal Q2 earnings results before the market opens on Thursday, Aug. 1.

Ahead of the event, analysts expect BIIB to report a profit of $3.98 per share, down 1% from $4.02 per share in the year-ago quarter. In the last four quarters, the company has surpassed Wall Street’s bottom-line estimates in three and missed on another occasion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.